Using longitudinal MRI radiomics, biochemical biomarkers, and clinical factors improves prediction of progression in knee OA.

The overall discontinuation rate of medical cannabis use was 57.9% at 1 year among patients with musculoskeletal pain.

BoneXpert and IB-lab-PANDA demonstrated accurate bone age evaluations against manual ratings among pediatric patients with GHD.

The ACR recently issued the first formal international consensus guidance statement on diagnosing and managing VEXAS syndrome ...

Cemdisiran is a subcutaneously-administered, small interfering RNA therapeutic that reduces the production of complement factor 5 in the liver.

Interquartile range increase in the cumulative exposure to heatwaves were associated with 0.023- to 0.031-year increases in biological age.

Very abnormal laboratory results were often already known or suspected or thought to be unrelated to DMARD use in RA.

Oral semaglutide was linked to reduced SU levels among patients with T2D, particularly among individuals with hyperuricemia and those who switched from a DPP-4 inhibitor.

Relative risks for all-cause, cardiovascular, and respiratory mortality were larger for fire-related PM2.5 than total PM2.5.

Topline results were announced from a phase 3 trial evaluating efgartigimod alfa-fcab in patients with AChR-Ab seronegative generalized myasthenia gravis.

In Alaska, AN/AI adults have a significantly higher incidence and prevalence of SjD compared with estimates found in other populations.